Emerging from the UK, retatrutide, a new compound , is creating considerable interest within the scientific community regarding its potential for weight regulation. This dual GIP and GLP-1 target agonist seems to deliver a considerable improvement over established therapies, showing encouraging results in initial clinical trials . Researchers th… Read More